BILL · 2025–26 SESSION
SB 5921: Psilocybin
Concerning psilocybin.
Summary
- Creates a program allowing licensed clinicians to administer psilocybin products to qualifying patients.
- Directs the Department of Health to develop a program and rules allowing the production and administration of psilocybin products.
- Provides legal protections for licensed clinicians, licensed producers, and qualifying patients participating in the program.
From the Senate Bill Report (SB 5921), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedJan 12, 2026
- Out of committeestopped here
- Passed Senate
- Passed House
- Governor
- Law
- Prime sponsor
- Jesse Salomon (D-32)
- Introduced
- January 12, 2026 in the Senate
- Last action
- February 4, 2026
- Budget
- Has a fiscal note
AN ACT Relating to psilocybin;
Sponsors
Prime sponsor: Jesse Salomon (D-32)
6 co-sponsors (6 Democrats, 0 Republicans)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- Referred to Ways & Means.
- Minority; without recommendation.
- Minority; do not pass.
- And refer to Ways & Means.
- HLTC - Majority; do pass.
- First reading, referred to Health & Long-Term Care.
- Prefiled for introduction.
SB 5921 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- SB 5921 (2023–24) Tribal rep./conserv. comm'n
- SB 5921 (2021–22) County timber tax distrib.
- SB 5921 (2019–20) Community respite services
- SB 5921 (2017–18) Telecomm srvs/electric rates
- SB 5921 (2015–16) Land use permit process
- SB 5921 (2013–14) Additive trans. funding
- SB 5921 (2011–12) Social services programs
- SB 5921 (2009–10) Clean energy initiative